Pierre Fabre Laboratories Begins New Chapter in the US
Pierre Fabre Laboratories, a prominent French healthcare firm, has recently inaugurated its new office in Secaucus, New Jersey. This strategic move represents a critical evolution for the company, signifying its intent to strengthen its presence in the US market, particularly in dermo-cosmetics and medical care.
Expansion in Dermo-Cosmetics and Medical Sectors
Pierre Fabre is known globally as the second-largest manufacturer in dermo-cosmetics and maintains a strong foothold in oncology, cell, and gene therapy, and rare diseases. The new facility will host the company's dermo-cosmetics and medical care divisions, reflecting its ambition to cater to the increasing demand for French skincare products in the US.
Having established the brands Avène, Klorane, and René Furterer in the US during the 1990s, Pierre Fabre has observed a rising appetite for dermo-cosmetics among American consumers. Building on its success in Europe and Asia, the company has been investing heavily in expanding its medical care operations in the US. This includes launching a dedicated pharmaceutical unit, Pierre Fabre Pharmaceuticals (PFP), aimed at delivering innovative therapies for rare diseases and oncology – areas marked by significant unmet healthcare needs.
A Commitment to Growth in the US Market
Eric Ducournau, the CEO of Pierre Fabre Laboratories, underscored the importance of US operations, stating, "we have declared the United States a priority geography for the company." The US market, being the largest for both pharmaceuticals and cosmetics and also characterized by rapid therapeutic innovation, presents great opportunities for the company. Ducournau highlighted that their flagship brand, Eau Thermale Avène, has seen a tenfold increase in turnover since 2010, pointing to the brand's vast potential within the American cosmetic landscape.
Secaucus was chosen for its strategic location, providing quick transportation links to New York City and the broader tri-state area. This office is designed not just as a workspace but as an environment that embodies Pierre Fabre's core values of sustainability and innovation. It features educational spaces aimed at offering immersive experiences in skin and hair care, promoting a creative and collaborative culture among employees.
Lisa Morris, President and CEO of Pierre Fabre USA, expressed enthusiasm about the new office, remarking, "This new office is more than just a space; it's a hub for collaboration and showcases our commitment to care across all business units in dermo-cosmetics and pharmaceuticals." The establishment of this new Tennessee office reflects Pierre Fabre's dedication to building a robust organizational presence aimed at delivering innovative healthcare solutions in the US.
Adriana Herrera, CEO of PFP, added that this expansion marks a turning point for their operations in medical care, which have focused on creating long-term value through innovative therapies for patients battling cancer. The company's mission is to provide hope and effective treatment options to individuals facing urgent health challenges.
Conclusion: A Bold Step Forward
With the inauguration of its US office, Pierre Fabre Laboratories is poised to enhance its impact within the American healthcare landscape, focusing on both dermo-cosmetics and pharmaceuticals. This expansion not only signals a growth period for the company but also illustrates its commitment to meeting the needs of American patients and healthcare professionals alike. As the company progresses, it aims to further solidify its role as a leader in the industry, utilizing its extensive experience and expertise to deliver innovative solutions that truly make a difference in people's lives.
For more information about Pierre Fabre Laboratories, visit
pierre-fabre.com or
pierrefabrepharmaceuticals.com and follow their updates on Instagram at @aveneusa.